Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Waugh

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanismAndrea Valentine, Martin O'Rourke, Anita Yakkundi, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Cancer Letters|January 4, 2025
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancerMadison T Hindes, Anthony M McElligott, Oliver G Best, et al.
The Review of Scientific Instruments|May 8, 2012
Upgrade of the MIT Linear Electrostatic Ion Accelerator (LEIA) for nuclear diagnostics development for Omega, Z and the NIFN Sinenian, M J-E Manuel, A B Zylstra, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2016
Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerPhilip D Dunne, Darragh G McArt, Conor A Bradley, et al.
Cancer|December 24, 2015
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer ProgramMark Lawler, Anna Gavin, Manuel Salto-Tellez, et al.
Cancers|January 11, 2025
Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate CancerBukuru Dieu-Donne Nturubika, Jessica Logan, Ian R D Johnson, et al.
The Review of Scientific Instruments|May 3, 2014
Empirical assessment of the detection efficiency of CR-39 at high proton fluence and a compact, proton detector for high-fluence applicationsM J Rosenberg, F H Séguin, C J Waugh, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanismAndrea Valentine, Martin O'Rourke, Anita Yakkundi, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Cancer Letters|January 4, 2025
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancerMadison T Hindes, Anthony M McElligott, Oliver G Best, et al.
The Review of Scientific Instruments|May 8, 2012
Upgrade of the MIT Linear Electrostatic Ion Accelerator (LEIA) for nuclear diagnostics development for Omega, Z and the NIFN Sinenian, M J-E Manuel, A B Zylstra, et al.
Oncotarget|April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunitiesZenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2016
Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal CancerPhilip D Dunne, Darragh G McArt, Conor A Bradley, et al.
Cancer|December 24, 2015
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer ProgramMark Lawler, Anna Gavin, Manuel Salto-Tellez, et al.
Cancers|January 11, 2025
Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate CancerBukuru Dieu-Donne Nturubika, Jessica Logan, Ian R D Johnson, et al.
The Review of Scientific Instruments|May 3, 2014
Empirical assessment of the detection efficiency of CR-39 at high proton fluence and a compact, proton detector for high-fluence applicationsM J Rosenberg, F H Séguin, C J Waugh, et al.
Pageof 21